Ticker Symbol: HMTGF
Human Metabolome Technologies Inc
Exchange: US OTC
Country:
JP
Currency:
USD
Asset
Type: Common Stock
Company Profile
Human Metabolome Technologies, Inc. engages in the business of diagnostic technology and medical products. Its operations are carried out through the following segments: Metabolome Analysis, Biomarker, and Temporary Staffing. The Metabolome Analysis segment provides contract analysis service based on the metabolome analysis on measured samples from the clients. The Biomarker segment deals with the development of biomarker license in collaboration with the group companies. The Temporary Staffing segment provides researchers and technicians. The company was founded by Yoshihiro Otaki, Masaru Tomita, and Tomoyoshi Soga on July 1, 2003 and is headquartered in Tsuruoka, Japan.
Sector: Health Technology
Industry: Biotechnology
Standard Industrial Classification Code (SIC code): 8071
Address: 246-2 Mizukami
Website: http://humanmetabolome.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-$0.80
(
-4.10%)
Days Range: $18.70 - $19.50
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change -4.10%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 5900300
Valuation
Market Cap: 11.0B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: June 29, 2022